Showing results (161-170 of 569) with videos related to

Sort By:
Pageof 57
The Journal of Biological Chemistry|October 18, 2025
Mutagenesis of the PALB2 WD40 domain identifies variants defective in interaction with BRCA2 and DNA repairThiago T Gomes, Anna Beatriz R Elias, Huaizhi Huang, et al.
Cancer|October 8, 2019
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st centurySiddhartha Yadav, Dhauna Karam, Irbaz Bin Riaz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas NetworkYujing J Heng, Susan E Hankinson, Jun Wang, et al.
Biomed Research International|June 25, 2015
Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal AdenocarcinomaAlan R Penheiter, Sibel Erdogan, Stephen J Murphy, et al.
Gastroenterology|August 6, 2013
Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumorStephen J Murphy, Steven N Hart, Joema Felipe Lima, et al.
International Journal of Molecular Sciences|March 25, 2017
Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE SpecimensOlivier Loudig, Tao Wang, Kenny Ye, et al.
Breast Cancer Research : BCR|November 27, 2007
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?Paul K Lovelock, Amanda B Spurdle, Myth T S Mok, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerJohanna I Kiiski, Liisa M Pelttari, Sofia Khan, et al.
American Journal of Human Genetics|February 20, 2021
Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significanceMarcy E Richardson, Chunling Hu, Kun Y Lee, et al.
Science Translational Medicine|January 14, 2026
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancerJulie R Duffield, Xiaonan Hou, Benjamin W Wilson, et al.
Pageof 57